// Biotech and Pharma Therapeutics Avidity drug for muscular dystrophy shows promise; Syntis takes new approach to weight loss June 12, 2024 / Avidity Biosciences / Muscular Dystrophy Treatment / Weight Loss Therapy Avidity’s del-brax shows >50% gene reduction in...